Correlation Between Apex Biotechnology and Taiwan Mobile

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Apex Biotechnology and Taiwan Mobile at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apex Biotechnology and Taiwan Mobile into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apex Biotechnology Corp and Taiwan Mobile Co, you can compare the effects of market volatilities on Apex Biotechnology and Taiwan Mobile and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apex Biotechnology with a short position of Taiwan Mobile. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apex Biotechnology and Taiwan Mobile.

Diversification Opportunities for Apex Biotechnology and Taiwan Mobile

0.44
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Apex and Taiwan is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Apex Biotechnology Corp and Taiwan Mobile Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Taiwan Mobile and Apex Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apex Biotechnology Corp are associated (or correlated) with Taiwan Mobile. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Taiwan Mobile has no effect on the direction of Apex Biotechnology i.e., Apex Biotechnology and Taiwan Mobile go up and down completely randomly.

Pair Corralation between Apex Biotechnology and Taiwan Mobile

Assuming the 90 days trading horizon Apex Biotechnology Corp is expected to under-perform the Taiwan Mobile. But the stock apears to be less risky and, when comparing its historical volatility, Apex Biotechnology Corp is 1.08 times less risky than Taiwan Mobile. The stock trades about -0.1 of its potential returns per unit of risk. The Taiwan Mobile Co is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  11,350  in Taiwan Mobile Co on September 2, 2024 and sell it today you would lose (50.00) from holding Taiwan Mobile Co or give up 0.44% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Apex Biotechnology Corp  vs.  Taiwan Mobile Co

 Performance 
       Timeline  
Apex Biotechnology Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Apex Biotechnology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Apex Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Taiwan Mobile 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Taiwan Mobile Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Taiwan Mobile is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Apex Biotechnology and Taiwan Mobile Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Apex Biotechnology and Taiwan Mobile

The main advantage of trading using opposite Apex Biotechnology and Taiwan Mobile positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apex Biotechnology position performs unexpectedly, Taiwan Mobile can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Taiwan Mobile will offset losses from the drop in Taiwan Mobile's long position.
The idea behind Apex Biotechnology Corp and Taiwan Mobile Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings